Celldex Therapeutics | CLDX - Ebit

Stock Price
29.51
Daily Change
4.67 18.78%
Monthly
11.05%
Yearly
41.85%
Q1 Forecast
22.31

Celldex Therapeutics reported $-73.62M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Agenus USD -13.31M 19.08M Mar/2025
Amgen USD 3.96B 464M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Celldex Therapeutics USD -73.62M 9.76M Sep/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Northwest Biotherapeutics USD -13.82M 248K Sep/2023
Pfizer USD 4.65B 71M Dec/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 9.56B 2.1B Dec/2025